Correlation Between Neurosense Therapeutics and Kiora Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neurosense Therapeutics and Kiora Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurosense Therapeutics and Kiora Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurosense Therapeutics and Kiora Pharmaceuticals, you can compare the effects of market volatilities on Neurosense Therapeutics and Kiora Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurosense Therapeutics with a short position of Kiora Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurosense Therapeutics and Kiora Pharmaceuticals.
Diversification Opportunities for Neurosense Therapeutics and Kiora Pharmaceuticals
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Neurosense and Kiora is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Neurosense Therapeutics and Kiora Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiora Pharmaceuticals and Neurosense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurosense Therapeutics are associated (or correlated) with Kiora Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiora Pharmaceuticals has no effect on the direction of Neurosense Therapeutics i.e., Neurosense Therapeutics and Kiora Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neurosense Therapeutics and Kiora Pharmaceuticals
Given the investment horizon of 90 days Neurosense Therapeutics is expected to generate 1.53 times more return on investment than Kiora Pharmaceuticals. However, Neurosense Therapeutics is 1.53 times more volatile than Kiora Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Kiora Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 83.00 in Neurosense Therapeutics on August 23, 2024 and sell it today you would earn a total of 9.00 from holding Neurosense Therapeutics or generate 10.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurosense Therapeutics vs. Kiora Pharmaceuticals
Performance |
| Timeline |
| Neurosense Therapeutics |
| Kiora Pharmaceuticals |
Neurosense Therapeutics and Kiora Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurosense Therapeutics and Kiora Pharmaceuticals
The main advantage of trading using opposite Neurosense Therapeutics and Kiora Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurosense Therapeutics position performs unexpectedly, Kiora Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiora Pharmaceuticals will offset losses from the drop in Kiora Pharmaceuticals' long position.The idea behind Neurosense Therapeutics and Kiora Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Kiora Pharmaceuticals vs. ZyVersa Therapeutics | Kiora Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Kiora Pharmaceuticals vs. Zura Bio Limited | Kiora Pharmaceuticals vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |